Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases
The potent anticancer drug actinomycin D (ActD) acts by binding to DNA GpC sequences, thereby interfering with essential biological processes including replication, transcription and topoisomerase. Certain neurological diseases are correlated with expansion of (CTG)(n) trinucleotide sequences, which...
Guardat en:
| Publicat a: | Nucleic Acids Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12433994/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/nar/gkf619 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
